Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.

Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J.

Int J Mol Sci. 2019 Dec 27;21(1). pii: E212. doi: 10.3390/ijms21010212. Review.

2.

Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, Neuman MG, Rehm J.

Am J Gastroenterol. 2019 Oct;114(10):1574-1586. doi: 10.14309/ajg.0000000000000340.

PMID:
31464740
3.

Biomarkers of Drug-Induced Liver Toxicity.

Neuman MG.

Ther Drug Monit. 2019 Apr;41(2):227-234. doi: 10.1097/FTD.0000000000000610. Review.

PMID:
30883515
4.

Biomarkers of drug-induced liver toxicity.

Neuman MG.

Ther Drug Monit. 2019 Feb 19. doi: 10.1097/FTD.0000000000000610. [Epub ahead of print]

PMID:
30801568
5.

Non-alcoholic fatty liver disease: an update on diagnosis.

Dumitrascu DL, Neuman MG.

Clujul Med. 2018;91(2):147-150. doi: 10.15386/cjmed-993. Epub 2018 Apr 25. Review.

6.

Alcohol Misuse Link to POEMS Syndrome in a Patient.

Neary J, Goodwin SE, Cohen LB, Neuman MG.

Cancers (Basel). 2017 Sep 23;9(10). pii: E129. doi: 10.3390/cancers9100129.

7.

Pyrrolizidine alkaloids enhance alcohol-induced hepatocytotoxicity in vitro in normal human hepatocytes.

Neuman MG, Cohen LB, Steenkamp V.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):53-68.

8.

Severe hepatocytotoxicity linked to denosumab.

Malnick S, Maor Y, Melzer E, Ziv-Sokolowskaia NN, Neuman MG.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):78-85.

9.

Gastrointestinal Inflammation and Repair: Role of Microbiome, Infection, and Nutrition.

Oz HS, Yeh SL, Neuman MG.

Gastroenterol Res Pract. 2016;2016:6516708. doi: 10.1155/2016/6516708. Epub 2016 Dec 28. No abstract available.

10.

Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.

Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M.

Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7. Review.

PMID:
28077318
11.

Non-Alcoholic Steatohepatitis: Clinical and Translational Research.

Neuman MG, Voiculescu M, Nanau RM, Maor Y, Melzer E, Cohen LB, Opris M, Malnick S.

J Pharm Pharm Sci. 2016;19(1):8-24. doi: 10.18433/J3F61F. Review.

12.

Hepatotoxicity of Pyrrolizidine Alkaloids.

Neuman MG, Cohen L, Opris M, Nanau RM, Hyunjin J.

J Pharm Pharm Sci. 2015;18(4):825-43. Review.

13.

Alcoholic Liver Disease: Role of Cytokines.

Neuman MG, Maor Y, Nanau RM, Melzer E, Mell H, Opris M, Cohen L, Malnick S.

Biomolecules. 2015 Aug 28;5(3):2023-34. doi: 10.3390/biom5032023. Review.

14.

Alcoholic liver disease: Clinical and translational research.

Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P, Seitz HK, Mueller S, Mell H, Samuel D, Cohen LB, Kharbanda KK, Osna NA, Ganesan M, Thompson KJ, McKillop IH, Bautista A, Bataller R, French SW.

Exp Mol Pathol. 2015 Dec;99(3):596-610. doi: 10.1016/j.yexmp.2015.09.001. Epub 2015 Sep 3. Review.

PMID:
26342547
15.

Hyaluronic acid as a non-invasive biomarker of liver fibrosis.

Neuman MG, Cohen LB, Nanau RM.

Clin Biochem. 2016 Feb;49(3):302-15. doi: 10.1016/j.clinbiochem.2015.07.019. Epub 2015 Jul 17. Review.

PMID:
26188920
16.

Biomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions.

Nanau RM, Neuman MG.

Biomolecules. 2015 Jun 29;5(3):1339-85. doi: 10.3390/biom5031339. Review.

17.

Nonmedicinal interventions in nonalcoholic fatty liver disease.

Neuman MG, Nanau RM, Cohen LB.

Can J Gastroenterol Hepatol. 2015 Jun-Jul;29(5):241-52. Review.

18.

Quinolones-induced hypersensitivity reactions.

Neuman MG, Cohen LB, Nanau RM.

Clin Biochem. 2015 Jul;48(10-11):716-39. doi: 10.1016/j.clinbiochem.2015.04.006. Epub 2015 Apr 17. Review.

PMID:
25895484
19.

Hyaluronic acid and wound healing.

Neuman MG, Nanau RM, Oruña-Sanchez L, Coto G.

J Pharm Pharm Sci. 2015;18(1):53-60. Review.

20.

Risk of infections of biological therapies with accent on inflammatory bowel disease.

Nanau RM, Cohen LE, Neuman MG.

J Pharm Pharm Sci. 2014;17(4):485-531. Review.

Supplemental Content

Loading ...
Support Center